Kensington Investment Counsel, LLC Axonics, Inc. Transaction History

Kensington Investment Counsel, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $721,884 - $1.04 Million	-16,504 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $144,428 - $211,834	-2,888 Reduced 14.89%	16,504 $924,000
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $82,789 - $107,775	1,611 Added 9.06%	19,392 $1.23 Million
Q1 2021 May 13, 2021	BUY	$49.14 - $59.89 $873,758 - $1.06 Million	17,781 New	17,781 $1.07 Million

236

42.7M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.46B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Kensington Investment Counsel, LLC with notifications on news.